FDA Accepts Request for Rolling Review of MDMA-Assisted Therapy
On November 2, 2021, the U.S. Food and Drug Administration (FDA) granted MAPS PBC’s request for rolling submission and review of portions of our planned new drug application (NDA) for MDMA. Rolling …